Literature DB >> 8334997

Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.

P Jackson1, D Baltimore, D Picard.   

Abstract

Fusion of the hormone binding domain (HBD) of steroid receptors to transcription factors renders them hormone-dependent. We show here that an SH3-deleted, oncogenic variant of the Abl tyrosine kinase becomes hormone-dependent for transformation by fusion to the estrogen receptor (ER) HBD, extending the phenomenon to tyrosine kinases. Surprisingly, fusion of the HBD to the normal, non-transforming c-Abl (IV) protein activated transforming activity in a hormone-dependent fashion. In the presence of hormone, the c-Abl:ER fusion protein was transforming, cytoplasmic and tyrosine phosphorylated, whereas it was non-transforming, nuclear and hypophosphorylated without hormone. We have examined the kinetics of activation of the c-Abl:ER protein and found that protein synthesis is required both for kinase activation and for redistribution of the c-Abl:ER protein from the nucleus to the cytoplasm. We suggest that the activation of c-Abl could be due to HBD-mediated dimerization and/or to the ability to overexpress conditionally the normally toxic c-Abl protein. This novel approach may be applicable to a wide variety of proteins, particularly when activating mutations or physiological inducers are unknown or when the protein is toxic to cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334997      PMCID: PMC413531          DOI: 10.1002/j.1460-2075.1993.tb05942.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 2.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

3.  P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.

Authors:  M L Campbell; W Li; R B Arlinghaus
Journal:  Oncogene       Date:  1990-05       Impact factor: 9.867

Review 4.  Ligand-regulated nonspecific inactivation of receptor function: a versatile mechanism for signal transduction.

Authors:  K R Yamamoto; P J Godowski; D Picard
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1988

5.  Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor.

Authors:  S E Fawell; J A Lees; R White; M G Parker
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

6.  Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

Authors:  T G Lugo; A M Pendergast; A J Muller; O N Witte
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

7.  A novel 53 kDa protein complexed with P210bcr-abl in human chronic myelogenous leukemia cells.

Authors:  W J Li; W S Kloetzer; R B Arlinghaus
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

Review 8.  CCAAT-enhancer binding protein: a component of a differentiation switch.

Authors:  R M Umek; A D Friedman; S L McKnight
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

Review 9.  A function for the lck proto-oncogene.

Authors:  J B Bolen; A Veillette
Journal:  Trends Biochem Sci       Date:  1989-10       Impact factor: 13.807

10.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.

Authors:  L Tora; A Mullick; D Metzger; M Ponglikitmongkol; I Park; P Chambon
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  10 in total

Review 1.  Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.

Authors:  E C LaCasse; Y A Lefebvre
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

2.  Regulation of Cre recombinase activity by the synthetic steroid RU 486.

Authors:  C Kellendonk; F Tronche; A P Monaghan; P O Angrand; F Stewart; G Schütz
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

3.  Splinkerettes--improved vectorettes for greater efficiency in PCR walking.

Authors:  R S Devon; D J Porteous; A J Brookes
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

4.  A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor.

Authors:  J McGuire; M L Whitelaw; I Pongratz; J A Gustafsson; L Poellinger
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

5.  Cells transformed by a v-Myb-estrogen receptor fusion differentiate into multinucleated giant cells.

Authors:  U Engelke; D M Wang; J S Lipsick
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms.

Authors:  P J Welch; J Y Wang
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

7.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

8.  The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

Authors:  S T Wen; P K Jackson; R A Van Etten
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

9.  A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.

Authors:  M G Tomlinson; D B Woods; M McMahon; M I Wahl; O N Witte; T Kurosaki; J B Bolen; J A Johnston
Journal:  BMC Immunol       Date:  2001-06-08       Impact factor: 3.615

10.  Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK.

Authors:  Fiona Hey; Catherine Andreadi; Catherine Noble; Bipin Patel; Hong Jin; Tamihiro Kamata; Kees Straatman; Jinli Luo; Kathryn Balmanno; David T W Jones; V Peter Collins; Simon J Cook; Christopher J Caunt; Catrin Pritchard
Journal:  Heliyon       Date:  2018-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.